Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intra-Operative Electron Boost and Hypofractionated Whole-Breast Irradiation During Breast-conserving Treatment (BCT) (HIOB)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Paracelsus Medical University
Sponsor:
Collaborators:
LKH Klagenfurt
Poznan University of Medical Sciences
San Filippo Neri General Hospital
Avera McKennan Hospital & University Health Center
St. Luke’s Hospital ,Cedar Rapids, US
A.O.U. San Giovanni Battista di Torino, Italy
IRCCS-CROB Reference Cancer Center Baslilicata, Italy
Heinrich-Heine University, Duesseldorf
St. Elisabeth-Hospital Köln-Hohenlind, Germany
S.C. Radiotherapia Aziendale Umbria, Italy
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Fondazione Salvatore Maugeri
Marien Hospital Düsseldorf, Germany
A.O.U. Maggiore Della Carita, Novara, Italy
Philipps University Marburg Medical Center
Information provided by (Responsible Party):
Prof. Sedlmayer, Paracelsus Medical University
ClinicalTrials.gov Identifier:
NCT01343459
First received: April 26, 2011
Last updated: September 18, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2021
  Estimated Primary Completion Date: March 2021 (Final data collection date for primary outcome measure)